Revealing facts behind spray dried solid dispersion technology used for solubility enhancement

Saudi Pharmaceutical Journal

Volumn 23, Issue 4, 2015, Pages 352-365

  Patel, Bhavesh B ^a,b   Patel, Jayvadan K ^c   Chakraborty, Subhashis ^b   Shukla, Dali ^d  

^a HEMCHANDRACHARYA NORTH GUJARAT UNIVERSITY   (India)

^b Evonik Degussa India Pvt Ltd   (India)

^c NOOTAN PHARMACY COLLEGE   (India)

^d BANARAS HINDU UNIVERSITY   (India)

Author keywords

Amorphous solid dispersion; Quality by Design; Selection of polymer; Solubility enhancement; Spray drying

Indexed keywords

DRUG CARRIER; DRUG SOLVENT; LACTOSE; POLYMER; SILICON DIOXIDE; STABILIZING AGENT;

AIR TEMPERATURE; CRYSTALLIZATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG INDUSTRY; DRUG QUALITY; DRUG SCREENING; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; NEBULIZATION; PROCESS DEVELOPMENT; PROCESS TECHNOLOGY; QUALITY BY DESIGN; REPRODUCIBILITY; REVIEW; SCALE UP; SOLUBILITY; SPRAY DRIED SOLID DISPERSION TECHNOLOGY; SPRAY DRYING; SURFACE PROPERTY;

EID: 84942369852     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2013.12.013     Document Type: Review

References (100)

1. Aejaz A., Jafar M., Dehghan M., Shareef A. Meloxicam-PVP-SLS ternary solid dispersion system: in vitro and in vivo evaluation. Int. J. Pharm. Pharm. Sci. 2010, 2:182-190.
2. Al-Asheh S., Jumah R., Banat F., Hammad S. The use of experimental factorial design for analysing the effect of spray dryer operating variables on the production of tomato powder. Food Bioprod. Part C 2003, 81-88.
3. Alexander K., King C.F. Factors governing surface morphology of spray-dried amorphous substances. Drying Technol. 1985, 3:321-348.
4. Al-Obaidi H., Ke P., Brocchini S., Buckton G. Characterization and stability of ternary solid dispersions with PVP and PHPMA. Int. J. Pharm. 2011, 419:20-27.
5. Amaro M.I., Tajber L., Corrigan O.I., Healy A.M. Optimization of spray drying process conditions for sugar nanoporous microparticles (Npmps) intended for inhalation. Int. J. Pharm. 2011, 421:99-109.
6. Ambike A.A., Mahadik K.R., Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm. Res. 2005, 22:990-998.
7. Arnum P.V. Meeting solubility challenges. Pharm. Technol. 2012, 1:36-38.
8. Arpagaus, C., Schwatzbach, H., 2008. Scale-up from bench-top research to laboratory production. Buchi Technical Bulletin. http://www.buchi.com.
9. Baird J.A., Taylor L.S. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv. Drug Deliv. Rev. 2012, 64:396-421.
10. Baldinger A., Clerdent L., Rantanen J., Yang M., Grohganz H. Quality by design approach in the optimization of the spray-drying process. Pharm. Dev. Technol. 2012, 17:389-397.
11. Barillaro V., Pescarmona P.P., Speybroeck M.V. High-throughput study of phenytoin solid dispersions: formulation using an automated solvent casting method, dissolution testing, and scaling-up. J. Comb. Chem. 2008, 10:637-643.
12. Beck C., Sieven L., Gartner K. Effects of stabilizers on particle redispersion and dissolution from polymer strip films containing liquid antisolvent precipitated griseofulvin particles. Powder Technol. 2013, 236:37-51.
13. Behera A.L., Sahoo S.K., Patil S.V. Enhancement of solubility: A pharmaceutical overview. Der Pharmacia Lett. 2010, 2:310-318.
14. Bhinse S.D. Ternary solid dispersions of fenofibrate with poloxamer 188 and TPGS for enhancement of solubility and bioavailability. Int. J. Res. Pharm. Biomed. Sci. 2011, 2:583-595.
15. Bittner B., Kissel T. Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. J. Microencapsulation 1999, 16:325-341.
16. Buchi. The influence of the different process parameters on the dependent variables in spray drying method. Buchi Training Documents. http://www.buchi.com.
17. Cabral-Marques H., Almeida R. Optimisation of spray-drying process variables for dry powder inhalation formulations of corticosteroid/cyclodextrin inclusion complexes. Eur. J. Pharm. Biopharm. 2009, 73:121-129.
18. Cal K., Sollohub K. Spray drying technique. I: Hardware and process parameters. J. Pharm. Res. 2010, 99:575-586.
19. Calahan, J.L., 2011. Characterization of amorphous solid dispersions of AMG 517 in HPMC-AS and crystallization using isothermal microcalorimetry (Ph.D. thesis). University of Kansas. http://kuscholarworks.ku.edu/dspace/handle/1808/7647.
20. Chauhan B., Shimpi S., Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 2005, 26:219-230.
21. Chen R., Okamoto H., Danjo K. Preparation of functional composite particles of salbutamol sulfate using a 4-fluid nozzle spray-drying technique. Chem. Pharm. Bull. 2008, 56:254-259.
22. Crowley K.J., Zografi G. Water vapor absorption into amorphous hydrophobic drug/poly (vinylpyrrolidone) dispersions. J. Pharm. Sci. 2002, 91:2150-2165.
23. Dai W.G., Dong L.C., Li S. Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material. Int. J. Pharm. 2007, 336:1-11.
24. Dai W.G., Pollock-dove C., Dong L.C., Li S. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation. Adv. Drug Deliv. Rev. 2008, 60:657-672.
25. Dhirendra K., Lewis S., Udupa N., Atin K. Solid dispersion: a review. Pak. J. Pharm. Sci. 2009, 22:234-246.
26. Dobry D.E., Settell D.M., Baumann J.A. A model-based methodology for spray drying process development. J. Pharm. Innov. 2009, 4:133-142.
27. Duarte I., Temtem M., Gil M., Gaspar F. Overcoming poor bioavailability through amorphous solid dispersions. Ind. Pharm. 2011, 30:4-6.
28. Esposito E., Roncarati R., Cortesi R. Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics. Pharm. Dev. Technol. 2005, 5:267-278.
29. Fakhree A.A., Delgado D.R., Martinez F., Jouyban A. The importance of dielectric constant for drug solubility prediction in binary solvent mixtures: electrolytes and zwitterions in water+ethanol. AAPS Pharm. Sci. Tech. 2010, 11:1726-1729.
30. Ghebremeskel A.N., Vemavarapu C., Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble drug: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int. J. Pharm. 2007, 328:119-129.
31. Gil M., Vicente J., Gaspar F. Scale-up methodology for pharmaceutical spray drying. Chem. Today 2010, 28:18-22.
32. Giri T.K., Alexander A., Tripathi D.K. Physicochemical classification and formulation development of solid dispersion of poorly water soluble drugs: an updated review. Int. J. Pharm. Biol. Arch. 2010, 1:309-324.
33. Gohel, M.C., 2009. Spray drying: a review. http://www.pharmainfo.net/reviews/spray-drying-review.
34. Harjunen P., Lehto V.P., Vallisari J. Effects of ethanol to water ratio in feed solution on the crystallinity of spray-dried lactose. Drug Dev. Ind. Pharm. 2002, 28:949-955.
35. Healy A.M., McDonald B.F., Tajber L., Corrigan O.I. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. Eur. J. Pharm. Biopharm. 2008, 69:1182-1186.
36. Hite, M., Turner, S., Federici, C., 2003. Part 1: Oral delivery of poorly soluble drugs. pharmaceutical manufacturing and packing issue. Drugs Pharm. Manuf. Packing Source. http://www.scolr.com/lit/PMPS_2003_1.pdf.
37. Hugo M., Kunath K., Dressman J. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate. Drug Dev. Ind. Pharm. 2013, 39:402-412.
38. Huntington D.H. The influence of spray drying process on product properties. Drying Technol. 2004, 22:1261-1287.
39. ICH Impurities: Guideline for residual solvents Q3C (R5) Current Step 4 version dated 4 February 2011. International Conference on Harmonisation, Geneva.
40. ICH Topic Q3C (R5) Impurities: Guideline for residual solvents. European Medicines Agency, 2011. March 2011 EMA/CHMP/ICH/82260/2006.
41. Jouyban A., Soltanpour S., Chan H.K. A simple relationship between dielectric constant of mixed solvents with solvent composition and temperature. Int. J. Pharm. 2004, 269:353-360.
42. Kanno H., Taylor L.S. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J. Pharm. Sci. 2006, 95:2692-2705.
43. Kapoor B., Kaur R., Kour S. Solid dispersion: an evolutionary approach for solubility enhancement of poorly water soluble drugs. Int. J. Rec. Adv. Pharm. Res. 2012, 2:1-16.
44. Kuang, L.L., Chi-Hwa, W., Smith, K.A., 2012. On the fabrication of microparticles using electrohydrodynamic atomization method. http://www.dspace.mit.edu/bitstream/handle/1721.1/7480/MEBCS009.pdf.
45. Kumar A., Sahoo S.K., Padhee K. Review on solubility enhancement techniques for hydrophobic drugs. Int. J. Comp. Pharm. 2011, 3:1-7.
46. Laitinen, R., Lobmann, K., Strachan, C.J., 2012. Emerging trends in the stabilization of amorphous drugs. Int. J. Pharm. doi:10.1016/j.ijpharm.2012.04.066.
47. Lastow O., Andersson J., Nilsson A., Balachandran W. Low-voltage electro hydrodynamic spray drying of respirable particles. Pharm. Dev. Technol. 2007, 12:175-181.
48. Lebrun P., Krier F., Mantanus J., Grohganz H., Yang M., Rozet E., Boulanger B., Evrard B., Rantanen J., Hubert P. Design space approach in the optimization of the spray-drying process. Eur. J. Pharm. Biopharm. 2012, 80:226-234.
49. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50:47-60.
50. Littringer E.M., Mescher A., Eckhard S. Spray drying of mannitol as a drug carrier-the impact of process parameters on product properties. Drying Technol. 2012, 30:114-124.
51. Maghraby G.M.E., Alomrani A. Effect of binary and ternary solid dispersion on the in-vitro dissolution and in-situ rabbit intestinal absorption of gliclazide. Pak. J. Pharm. Sci. 2011, 24:459-468.
52. Mahajan H.S., Girnar G.A., Nerkar P. Dissolution and bioavailability enhancement of gliclazide by surface solid dispersion using spray drying technique. Indian J. Novel Drug Deliv. 2012, 4:115-124.
53. Mahapatra A.K., Murthy P.N., Rani E.R. An updated review on technical advances to enhance dissolution rate of hydrophobic drugs. Int. Res. J. Pharm. 2012, 3:1-7.
54. Mahdjoub H., Roy P., Filiatre C., et al. The effect of the slurry formulation upon the morphology of spray-dried yia stabilised zirconia particles. J. Eur. Ceram. Soc. 2003, 23:1637-1648.
55. Makai Z., Bajdik J., Eros I., Hodi K.P. Evaluation of the effects of lactose on the surface properties of alginate coated trandolapril particles prepared by a spray-drying method. Carbohydr. Polym. 2008, 74:712-716.
56. Maltesen M.J., Bjerregaard S., Hovgaard L., Havelund S., van de Weert M. Quality by design- spray drying of insulin intended for inhalation. Eur. J. Pharm. Biopharm. 2008, 70:828-838.
57. Martins, R.M., Pereira, S.V., Machado, M.O., 2011. Preparation of microparticles of hydrochlorthiazide by spray drying. In: European Drying Conference - Euro Drying.
58. Masky P., Dai W.G., Li S. Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing. J. Pharm. Sci. 2007, 96:1548-1563.
59. Mass S.G., Schaldach G., Littringer E.M. The impact of spray drying outlet temperature on the particle morphology of mannitol. Powder Technol. 2011, 213:27-35.
60. Maury M., Murphy K., Kumar S. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray dryer. Eur. J. Pharm. Biopharm. 2005, 59:565-573.
61. Maury M., Murphy K., Sandeep K., Shi L., Lee G. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer. Eur. J. Pharm. Biopharm. 2005, 59:565-573.
62. Mizoe T., Beppu S., Ozeki T., Okada H. One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier. J. Control. Release 2007, 120:205-210.
63. Mohanachandran P.S., Sindhumol P.G., Kiran T.S. Enhancement of solubility and dissolution rate: an overview. Int. J. Comp. Pharm. 2010, 4:1-10.
64. Mooter G.V.D. The use of amorphous solid dispersions: a formulation strategy to overcome poor solubility and dissolution rate. Drug Discov. Today: Technol. 2011, 10.1016/j.ddtec.2011.10.002.
65. Muttil P., Kaur J., Kumar K. Inhalable microparticles containing large payload of antituberculosis drugs. Eur. J. Pharm. Sci. 2007, 32:140-150.
66. Naikwade S.R., Bajaj A.N., Gurav P. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study. AAPS Pharm. SciTech. 2009, 10:993-1012.
67. Papelis C., Um W., Russel C.E., Chapman J.B. Measuring the specific surface area of natural and manmade glasses: effects of formation process, morphology, and particle size. Colloids Surf. A: Physicochem. Eng. Aspects 2003, 215:221-239.
68. Paradkar A., Ambike A.A., Jadhav B.K., Mahadik K.R. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int. J. Pharm. 2004, 271:281-286.
69. Paramita V., Iida K., Yoshii H., Furuta T. Effect of additives on the morphology of spray-dried powder. Drying Technol. 2010, 28:323-329.
70. Patel R.P., Patel M.P., Suthar A.M. Spray drying technology: an overview. Indian J. Sci. Technol. 2009, 2:44-47.
71. Patel T.B., Patel L.D., Patel T.B. Enhancement of dissolution rate and oral absorption of drug insoluble in gastric fluid by spray dried microparticles. Int. J. Chem. Tech. Res. 2010, 2:185-193.
72. Patel T.B., Patel L.D. Formulation and development strategies for drugs insoluble in gastric fluid. Int. Res. J. Pharm. 2012, 3:106-113.
73. Paudel A., Mooter G.V. Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying. Pharm. Res. 2012, 29:251-270.
74. Paudel, A., Worku, Z. A., Meeus, J., 2012. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: Formulation and process considerations. Int. J. Pharm. (in press). doi:10.1016/j.ijpharm.2012.07.015.
75. Planinsek O., Kovacic B., Vrecer F. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int. J. Pharm. 2011, 406:41-48.
76. Poddar S.S., Nigade S.U., Singh D.K. Designing of ritonavir solid dispersion through spray drying. Der Pharmacia Lett. 2011, 3:213-223.
77. Pokharkar V.B., Mandpe L.P., Padamwar M.N. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol. 2006, 167:20-25.
78. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006, 29:278-287.
79. Prinn K.B., Constantino H.R., Tracy M. Statistical modelling of protein spray drying at the lab scale. AAPS Pharm. SciTech. 2002, 3:E4.
80. Rahmati M.R., Vetanara A., Parsian A.R. Effect of formulation ingredients on the physical characteristics of salmeterolxinafoate microparticles tailored by spray freeze drying. Adv. Powder Technol. 2013, 24:36-42.
81. Rattes A.L.R., Oliveira W.P. Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles. Powder Technol. 2007, 171:7-14.
82. Sareen S., Mathew G., Joseph L. Improvement in solubility of poor water soluble drugs by solid dispersion. Int. J. Pharm. Invest. 2012, 2:12-17.
83. Schwatzbach H. The possibilities and challenges of spray drying. Pharm. Technol. Eur. 2010, 22:5-8.
84. Shanbhag A., Rabel S., Nauka E. Method for screening of solid dispersion formulations of low-solubility compounds-miniaturization and automation of solvent casting and dissolution testing. Int. J. Pharm. 2008, 351:209-218.
85. Shen S.C., Ng W.K., Chia L. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int. J. Pharm. 2011, 410:188-195.
86. Shi D., Loxely A., Lee R.W., Fairhurst D. A novel spray drying technology to improve the bioavailability of BCS class II molecules. Drug Dev. Deliv. 2012, 12:1-7.
87. Shinde V.R., Pore Y.V., Rao J.V. Development and characterization of ternary solid dispersion systems of olmesartan medoxomil. Latin American J. Pharm. 2011, 30:2011-2015.
88. Shukla D., Chakraborty S., Singh S., Mishra B. Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications. Expert Opin. Drug Deliv. 2011, 8:207-224.
89. Stahl K., Claesson M., Lilliehorn P., Linden H., Backstrom K. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int. J. Pharm. 2002, 233:227-237.
90. Ciach T. Application of electro-hydro-dynamic atomization in drug delivery. J. Drug Deliv. Sci. Technol. 2007, 17:367-375.
91. Tajber L., Corrigan O.I., Healy A.M. Spray drying of budesonide, formoterol fumarate and their composites - II. Statistical factorial design and in vitro deposition properties. Int. J. Pharm. 2009, 367:86-96.
92. Takeuchi H., Nagira S., Yamamoto H., Kawashima Y. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int. J. Pharm. 2005, 293:155-164.
93. Thybo P., Hovgaard L., Lindelov J.S. Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion. Pharm. Res. 2008, 25:1610-1620.
94. Vasconcelos T., Sarmento B., Costa P. Solid dispersion as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 2007, 12:1068-1075.
95. Vehring R. Pharmaceutical particle engineering via spray drying. Pharm. Res. 2008, 25:999-1022.
96. Verma S., Rawat A., Kaul M., Saini S. Solid dispersion: a strategy for solubility enhancement. Int. J. Pharm. Tech. 2011, 3:1062-1099.
97. Wu J.X., Yang M., Berg F.V. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability. Eur. J. Pharm. Sci. 2011, 44:610-620.
98. Yu Lian. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 2001, 48:27-42.
99. Yu L.X., Lionberger R.A., Raw A.S., D'Costa R., Wu H., Hussain A.S. Applications of process analytical technology to crystallization processes. Adv. Drug Deliv. Rev. 2004, 56:349-369.
100. Yurteri C.U., Hartman R.P.A., Marijniseen J.C.M. Producing pharmaceutical particles via electrospraying with an emphasis on nano and nano structured particles - a review. KONA Powder Particle J. 2010, 28:91-115.